Find your next M&A target

Target Asia + Worldwide M&A projects with our guidance on matching, planning, due diligence & implementation.

Search Seller Projects – Europe, Healthcare

Page of 2
Europe: France

French medical device company seeking Chinese partners for market development

The company is a French medical device company, and its main business is research, development, production and sales of cervical cancer detection equipment, generating annual sales of over EUR 20 million with an EBITDA of 2 million euros.
Recently, the company is also actively studying covid testing equipment, and the test package developed by its wholly-owned subsidiary has been approved by the FDA, and has been included in the list of WHO licensed emergency use, and the test can be purchased worldwide within one year.
The company's cervical cancer detection equipment has been initially sold in China, where it hopes to find new partners, especially those with good resources in hospitals/laboratories/obstetricians and gynecologists.
Europe: Croatia

Croatian medical device manufacturer seeking investment

The company has developed, manufactured and sold medical devices for orthopedics and traumatology for more than 100 years.
Europe: Britain, United Kingdom

UK medtech SaaS firm with collaboration tool in medical imaging seeking investors

The company has developed a pioneering collaboration platform based on a medical imaging cloud for hospitals, clinics and imaging centers. It provides SaaS solutions for medical imaging management, archiving, viewing, and analysis. Most importantly, it enables medical imaging driven social and professional collaboration among users. In addition to its cloud platform, the company also provides many clinical "applications", such as virtual colonoscopy and vascular analysis.
Europe: Britain, United Kingdom

Britisch medical equipment manufacturer with hair removal and skin rejuvenation technology looking for investors.

The company designs and manufactures IPL (intense pulsed light) hair removal products for consumers. The company is unique in combining technological innovation with clinical understanding of skin-light interaction. The potential of the household devices is very promising. In addition to hair removal, there are opportunities to expand the application of the technology to skin rejuvenation, acne treatment and other beauty applications. In 2019, the turnover exceeded £ 40 million with an EBITDA above £ 7 million.
Europe: Britain, United Kingdom

British Biomedicine R&D firm with new drug against MRSA looking for investors

The company has developed a new anti-infection drug with outstanding and rapid bacterial activity against Staphylococcus aureus (SA), which is the biggest cause of nosocomial bacterial infection in the world. The leading drug has completed clinical trials funded by the US government. Different from traditional antibiotics, this drug shows excellent resistance to SA bacteria in the laboratory where it has produced a series of low bacterial resistance potentials, and can be used to prevent and treat MRSA infection. The company has been listed on the Alternative Investment Market (AIM), a sub-market of London Stock Exchange (LSE), with a market value of 19 million pounds.


Enquire for more information about our services, and how we can help solve challenges for your organization

Contact Us
The code is case-sensitive